Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 6.83
TPI's Cash to Debt is ranked higher than
73% of the 750 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 2.39 vs. TPI: 6.83 )
TPI' s 10-Year Cash to Debt Range
Min: 1.04   Max: No Debt
Current: 6.83

Equity to Asset 0.93
TPI's Equity to Asset is ranked higher than
97% of the 712 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 0.60 vs. TPI: 0.93 )
TPI' s 10-Year Equity to Asset Range
Min: -0.94   Max: 0.93
Current: 0.93

-0.94
0.93
Interest Coverage 21.26
TPI's Interest Coverage is ranked higher than
59% of the 462 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 90.51 vs. TPI: 21.26 )
TPI' s 10-Year Interest Coverage Range
Min: 20.57   Max: 9999.99
Current: 21.26

20.57
9999.99
F-Score: 5
Z-Score: 3.97
M-Score: -2.68
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 13.80
TPI's Operating margin (%) is ranked higher than
81% of the 713 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 9.34 vs. TPI: 13.80 )
TPI' s 10-Year Operating margin (%) Range
Min: -628.57   Max: 23.06
Current: 13.8

-628.57
23.06
Net-margin (%) 9.88
TPI's Net-margin (%) is ranked higher than
78% of the 713 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 7.50 vs. TPI: 9.88 )
TPI' s 10-Year Net-margin (%) Range
Min: -628.57   Max: 18.59
Current: 9.88

-628.57
18.59
ROE (%) 6.81
TPI's ROE (%) is ranked higher than
71% of the 716 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 7.00 vs. TPI: 6.81 )
TPI' s 10-Year ROE (%) Range
Min: -49.44   Max: 20.83
Current: 6.81

-49.44
20.83
ROA (%) 6.06
TPI's ROA (%) is ranked higher than
80% of the 745 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 3.95 vs. TPI: 6.06 )
TPI' s 10-Year ROA (%) Range
Min: -46.94   Max: 17.44
Current: 6.06

-46.94
17.44
ROC (Joel Greenblatt) (%) 16.74
TPI's ROC (Joel Greenblatt) (%) is ranked higher than
76% of the 735 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 14.63 vs. TPI: 16.74 )
TPI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -169.23   Max: 68.61
Current: 16.74

-169.23
68.61
Revenue Growth (%) 2.60
TPI's Revenue Growth (%) is ranked higher than
63% of the 549 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 5.10 vs. TPI: 2.60 )
TPI' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 457.2
Current: 2.6

0
457.2
EBITDA Growth (%) -7.60
TPI's EBITDA Growth (%) is ranked higher than
60% of the 504 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.00 vs. TPI: -7.60 )
TPI' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 19.1
Current: -7.6

0
19.1
EPS Growth (%) -16.80
TPI's EPS Growth (%) is ranked higher than
58% of the 506 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.70 vs. TPI: -16.80 )
TPI' s 10-Year EPS Growth (%) Range
Min: -16.8   Max: 19.6
Current: -16.8

-16.8
19.6
» TPI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

TPI Guru Trades in Q1 2013

Jim Simons 397,800 sh (New)
» More
Q2 2013

TPI Guru Trades in Q2 2013

Jim Simons 398,300 sh (+0.13%)
» More
Q3 2013

TPI Guru Trades in Q3 2013

Jim Simons 410,500 sh (+3.06%)
» More
Q4 2013

TPI Guru Trades in Q4 2013

Jim Simons 488,700 sh (+19.05%)
» More
» Details

Insider Trades

Latest Guru Trades with TPI



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 4.40
TPI's P/E(ttm) is ranked higher than
100% of the 527 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 25.60 vs. TPI: 4.40 )
TPI' s 10-Year P/E(ttm) Range
Min: 1.61   Max: 81.02
Current: 4.4

1.61
81.02
P/B 0.30
TPI's P/B is ranked higher than
99% of the 700 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 2.84 vs. TPI: 0.30 )
TPI' s 10-Year P/B Range
Min: 0.15   Max: 2.76
Current: 0.3

0.15
2.76
P/S 0.45
TPI's P/S is ranked higher than
97% of the 717 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 2.95 vs. TPI: 0.45 )
TPI' s 10-Year P/S Range
Min: 0.19   Max: 3.54
Current: 0.45

0.19
3.54
PFCF 6.70
TPI's PFCF is ranked higher than
98% of the 328 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 24.79 vs. TPI: 6.70 )
TPI' s 10-Year PFCF Range
Min: 4.54   Max: 100
Current: 6.7

4.54
100
Shiller P/E 3.00
TPI's Shiller P/E is ranked higher than
99% of the 363 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 25.59 vs. TPI: 3.00 )
TPI' s 10-Year Shiller P/E Range
Min: 1.49   Max: 3.48
Current: 3

1.49
3.48

Valuation & Return

vs
industry
vs
history
Price/Net Cash 1.20
TPI's Price/Net Cash is ranked higher than
97% of the 219 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 12.70 vs. TPI: 1.20 )
TPI' s 10-Year Price/Net Cash Range
Min: 0.71   Max: 9.48
Current: 1.2

0.71
9.48
Price/Net Current Asset Value 0.80
TPI's Price/Net Current Asset Value is ranked higher than
99% of the 317 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 9.80 vs. TPI: 0.80 )
TPI' s 10-Year Price/Net Current Asset Value Range
Min: 0.46   Max: 5.39
Current: 0.8

0.46
5.39
Price/Tangible Book 0.30
TPI's Price/Tangible Book is ranked higher than
99% of the 639 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 4.10 vs. TPI: 0.30 )
TPI' s 10-Year Price/Tangible Book Range
Min: 0.19   Max: 3.24
Current: 0.3

0.19
3.24
Price/DCF (Projected) 0.30
TPI's Price/DCF (Projected) is ranked higher than
98% of the 349 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.70 vs. TPI: 0.30 )
TPI' s 10-Year Price/DCF (Projected) Range
Min: 0.16   Max: 0.43
Current: 0.3

0.16
0.43
Price/Median PS Value 0.60
TPI's Price/Median PS Value is ranked higher than
94% of the 675 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.10 vs. TPI: 0.60 )
TPI' s 10-Year Price/Median PS Value Range
Min: 0.29   Max: 3.94
Current: 0.6

0.29
3.94
Price/Graham Number 0.30
TPI's Price/Graham Number is ranked higher than
99% of the 470 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 2.20 vs. TPI: 0.30 )
TPI' s 10-Year Price/Graham Number Range
Min: 0.14   Max: 2.63
Current: 0.3

0.14
2.63
Earnings Yield (Greenblatt) 9579.00
TPI's Earnings Yield (Greenblatt) is ranked higher than
100% of the 595 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 4.80 vs. TPI: 9579.00 )
TPI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.2   Max: 59233.7
Current: 9579

5.2
59233.7
Forward Rate of Return (Yacktman) -5.73
TPI's Forward Rate of Return (Yacktman) is ranked higher than
58% of the 531 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.45 vs. TPI: -5.73 )
TPI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6   Max: 27.6
Current: -5.73

-6
27.6

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Specialty & Generic
Compare:TKPYY, TEVA, AGN, FRX, MRX » details
Traded in other countries:60T.Germany
Tianyin Pharmaceutical Co., Inc was organized under the laws of the State of Delaware on August 20, 2002. It was formerly called Viscorp, Inc. In March 2006, Tianyin changed its status from an LLC to a corporation registered in the State of Delaware. It is a pharmaceutical company which through its indirect wholly-owned subsidiary Chengdu Tianyin Pharmaceutical Co., Ltd., a corporation organized and existing under the laws of the People's Republic of China. The Company is engaged primarily in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. The Company currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance program. It sells its prescription-based and OTC TCM and pharmaceutical products via regional distributors as well as directly to the hospitals, clinics, and pharmacies in China. The Company faces competition from domestic TCM manufacturers, as well as domestic and foreign pharmaceuticals with similar therapeutic effects. It uses over 120 different medicinal herbs as primary raw materials and procures its raw materials from various vendors and suppliers. The Company's manufacturing operations are subject to numerous laws, regulations, rules and specifications relating to human health and safety and the environment which address and regulate, among other matters, wastewater discharge, air quality and the generation, handling, storage, treatment, disposal and transportation of solid and hazardous wastes and releases of hazardous substances into the environment.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide